Research Day 2024
March 1, 2024
Marshall Student Center
The 34th Annual USF Health Research Day will be held on March 1, 2024. Research Day is a day-long event showcasing the best and the brightest researchers across all USF Health colleges, as well as guest researchers whose work focuses on the science of health. It also allows many of them to spotlight existing collaborations, as well as form new ones. Last year we had 457 poster display as well as 12 invited oral presenters. In total we had approximately 700 people attend the event.
New this year, we will be hosting a networking event on Thursday, February 29th, 2024. More information will be coming on this dynamic event.
|Date||Friday, March 1,2024|
|Event Website||Click here to submit your abstract|
|Poster Submission||Opening in January 2024|
|Coming in February 2024|
Posters will be printed this year as well as electronically submitted
All posters must be 3 ft wide x 4 ft high, portrait style layout.
Dr. David Hotlzman, Professor in the Department of Neurology at Washington University in St. Louis, will deliver the Roy H. Behnke Keynote Address at USF Health Research Day on Friday, March 1 at 9:00 a.m. in the USF Marshall Student Center Student Oval Theater.
David Holtzman received his BS (1983) and MD (1985) from Northwestern University followed by a Neurology residency at UCSF from 1985-1989. He did post-doctoral research at UCSF from 1989-1994. He moved to Washington University in 1994 as an Assistant Professor and after moving up the faculty ranks and he was Professor and Chair of Neurology at Washington University from 2003-2021. He is currently Professor of Neurology, Scientific Director of the Hope Center for Neurological Disorders, and Associate Director of the Knight ADRC. Some of his lab’s accomplishments include showing in part how APOE contributes to AD, development of biomarkers for AD, demonstration that synaptic activity and sleep affect Aβ and tau levels in vivo, describing the effects of APOE, TREM2, and microglia on tau-mediated neurodegeneration, and development of an anti-Aβ antibody in a phase III secondary prevention trial for AD (A4) and an anti-ApoE antibody being developed for human trials. Several of his honors include being a recipient of the Potamkin prize and MetLife award for research on Alzheimer’s disease, Rainwater Prize for outstanding innovation in neurodegenerative disease research, election to the National Academy of Medicine, election to the National Academy of Inventors, being appointed to the National Advisory council of the NINDS and NIA, the Chancellor’s award for innovation and entrepreneurship and the Carl and Gerty Cori award from Washington University, elected Fellow of the AAAS, and being past president of the American Neurological Association. Holtzman has trained over 70 graduate students, post-doctoral fellows, and physician-scientists, many of whom have gone on to successful careers in academia and industry.
Research Day 2024 Proposed Awards Listing
Awards Listing coming soon